Fülöp F - Search Results

1

Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies.

Zádori D, Klivényi P, Vámos E, Fülöp F, Toldi J, Vécsei L. Zádori D, et al. Among authors: fulop f. J Neural Transm (Vienna). 2009 Nov;116(11):1403-9. doi: 10.1007/s00702-009-0263-4. Epub 2009 Jul 18. J Neural Transm (Vienna). 2009. PMID: 19618107 Review.

2

Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease.

Zádori D, Nyiri G, Szonyi A, Szatmári I, Fülöp F, Toldi J, Freund TF, Vécsei L, Klivényi P. Zádori D, et al. Among authors: fulop f. J Neural Transm (Vienna). 2011 Jun;118(6):865-75. doi: 10.1007/s00702-010-0573-6. Epub 2010 Dec 31. J Neural Transm (Vienna). 2011. PMID: 21194001

3

Behavioural studies with a newly developed neuroprotective KYNA-amide.

Gellért L, Varga D, Ruszka M, Toldi J, Farkas T, Szatmári I, Fülöp F, Vécsei L, Kis Z. Gellért L, et al. Among authors: fulop f. J Neural Transm (Vienna). 2012 Feb;119(2):165-72. doi: 10.1007/s00702-011-0692-8. Epub 2011 Aug 5. J Neural Transm (Vienna). 2012. PMID: 21818601

4

Kynurenines in Parkinson's disease: therapeutic perspectives.

Zádori D, Klivényi P, Toldi J, Fülöp F, Vécsei L. Zádori D, et al. Among authors: fulop f. J Neural Transm (Vienna). 2012 Feb;119(2):275-83. doi: 10.1007/s00702-011-0697-3. Epub 2011 Aug 20. J Neural Transm (Vienna). 2012. PMID: 21858430 Review.

5

Modifications on the carboxylic function of kynurenic acid.

Fülöp F, Szatmári I, Toldi J, Vécsei L. Fülöp F, et al. J Neural Transm (Vienna). 2012 Feb;119(2):109-14. doi: 10.1007/s00702-011-0721-7. Epub 2011 Oct 14. J Neural Transm (Vienna). 2012. PMID: 21997444

6

A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study : special issue related to kynurenine.

Demeter I, Nagy K, Gellért L, Vécsei L, Fülöp F, Toldi J. Demeter I, et al. Among authors: fulop f. J Neural Transm (Vienna). 2012 Feb;119(2):151-4. doi: 10.1007/s00702-011-0755-x. Epub 2012 Jan 10. J Neural Transm (Vienna). 2012. PMID: 22231843

7

Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders.

Zádori D, Klivényi P, Szalárdy L, Fülöp F, Toldi J, Vécsei L. Zádori D, et al. Among authors: fulop f. J Neurol Sci. 2012 Nov 15;322(1-2):187-91. doi: 10.1016/j.jns.2012.06.004. Epub 2012 Jun 27. J Neurol Sci. 2012. PMID: 22749004 Review.

8

Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction.

Szalardy L, Zadori D, Toldi J, Fulop F, Klivenyi P, Vecsei L. Szalardy L, et al. Among authors: fulop f. Curr Top Med Chem. 2012;12(16):1797-806. Curr Top Med Chem. 2012. PMID: 23030614 Review.

9

Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease.

Zádori D, Szalárdy L, Toldi J, Fülöp F, Klivényi P, Vécsei L. Zádori D, et al. Among authors: fulop f. J Neural Transm (Vienna). 2013 Apr;120(4):673-81. doi: 10.1007/s00702-012-0930-8. Epub 2012 Nov 30. J Neural Transm (Vienna). 2013. PMID: 23196983 Review.

10

Kynurenines in the CNS: recent advances and new questions.

Vécsei L, Szalárdy L, Fülöp F, Toldi J. Vécsei L, et al. Among authors: fulop f. Nat Rev Drug Discov. 2013 Jan;12(1):64-82. doi: 10.1038/nrd3793. Epub 2012 Dec 14. Nat Rev Drug Discov. 2013. PMID: 23237916 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters